New hope for IVF patients: drug may prevent dangerous ovarian overreaction
NCT ID NCT07043322
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two methods to prevent ovarian hyperstimulation syndrome (OHSS), a serious side effect of fertility treatments. About 150 women at high risk for OHSS will receive either cabergoline or a standard 'coasting' procedure. The goal is to see which approach better reduces the occurrence and severity of OHSS.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GYNECOLOGIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mostafa Bahaa
RECRUITINGDamietta, New Damietta, 34518, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could talking directly to teens before surgery ease their pain?
- Could skipping bowel prep make surgery easier on patients?
- Hysterectomy study abandoned after just one patient
- Keyhole surgery blood loss study compares tying techniques
- Scientists hunt for immune clues behind unexplained infertility and miscarriage
- 25,000 ultrasound scans to train AI for better Women's health diagnosis